Disclosure: Contour runs the program this guide describes, so read it with that in mind.
The short version
- Buyers shortlist before they call: 94% of B2B buying groups rank their preferred vendors before first contact, per 6sense.
- Treat it as a supply problem: one recorded interview of about an hour a month gives you a month of material.
- Publish three posts a week. FDA Blueprint tested five and three worked better.
- Spend about five hours a week replying, because that’s where comments turn into DMs and discovery calls. Nobody can do that part for you.
- Judge it at 90 days. FDA Blueprint went from 3 or 4 qualified calls a month to 12 to 16, per the case study.
Why do referrals dry up the month you get busy?
Referrals dry up for independent regulatory consultants because the consultant is the product and the factory at the same time. Every hour that goes into a submission is an hour that doesn’t go into being visible, and the submission always wins, because that’s what pays this month. One regulatory consultant told me it straight: “When we get busy, we skip posting for a while, and then it dries up.” Nobody decides to stop marketing. It just stops, and the quiet shows up a quarter later.
I’m not writing this from above it, either. I sell a system for getting off referral dependence, and when I mapped my own pipeline this year, every client traced back to one person. One. It doesn’t feel like risk while it’s working. It feels like a good relationship.
Referrals also aren’t only old clients talking. In Hinge Research Institute’s 2015 referral study, 81.5% of professional services firms had received referrals from people who were never their clients. And 48.1% of those referrals were based on expertise the referrer had seen for themselves. The most common ways were hearing the expert speak (30%), reading their articles (20%) and interacting with them on social media (17%). The study is from 2015, but the mechanism hasn’t moved. When a consultant gets more visible, referrals usually go up too, from people they’ve never worked with.
Where do FDA buyers actually decide who to hire?
FDA buyers decide who to hire long before they call anyone. The same 6sense research found buyers purchase from their pre-contact favourite 77% of the time, and the average buying cycle now runs about 10 months. So the intro call isn’t where you win the work. By then the device company has mostly decided, and your job on the call is to not lose it.
AI is part of that research now, and a person still checks the answer. A Gartner survey of 645 B2B buyers, published in May 2026, found 45% had used generative AI to gather information on vendors and products. And 69% preferred to validate what the AI told them with a human. For a device company, that human is usually a consultant whose name came up in the research, in a feed or in a chat window, before the call was ever booked.
David Pudwill, who spent nine years inside FDA and now runs FDA Blueprint, put it better than I can. “The people who are coming to me have decided to work with me before they even arrange a call. I don’t have to win them over. I just have to not lose the sale.”
The market doing that research is not small. FDA cleared 9,659 510(k) submissions in the three years to September 2026, for 4,488 different applicants, according to openFDA’s 510(k) data. Contour pulled those figures on 17 September 2026. That’s thousands of device companies a year, each one reading, comparing and shortlisting before a first conversation, and most of them will never ask a colleague who to call.
Most device companies aren’t looking for a consultant yet, either. Edelman and LinkedIn’s 2024 B2B Thought Leadership Impact Report found only 5% of potential buyers in a category are actively in market at any time. The same report found 75% of decision-makers had researched something they weren’t considering because of a piece of thought leadership. Buyers are out there, so what matters is whether they already know your name when the problem lands on their desk.
What does that look like for a regulatory consultant? A founder reads your post about a Pre-Sub that went sideways, six months before their own Pre-Sub. They don’t comment. They don’t follow. But when the board asks who’s handling FDA, yours is the name they already have.
Who does this work for, and who shouldn’t bother?
A visibility pipeline works for independent regulatory consultants with narrow, deep expertise and engagements big enough that two or three extra clients a year pay for the whole thing. It doesn’t work for everyone, and it’s better you find that out here than three months in.
| This fits you if | This isn’t for you if |
|---|---|
| Your engagements run roughly 15k USD and up | Your typical project is small and one-off |
| You have a narrow niche: a device class, SaMD, IVDs, a pathway | You’re a generalist who does “FDA consulting” |
| Most of your work comes from people who already know you | You already have more inbound than you can take |
| You’ll sit for one hour-long interview a month | You want it 100% done for you, with zero involvement |
| You’ll reply to comments and messages yourself | You plan to post and disappear |
The last two rows are where most people drop out. If someone tells you this runs completely without you, they’re selling you the thing that didn’t work last time.
How does the Supply-First Pipeline work?
The Supply-First Pipeline treats a consultant’s content problem as a supply problem. It separates the part only the expert can do, talking about the work, from the parts that can be done by someone else. The expert gives one hour a month and a few hours a week of conversation. Everything in between is production.
| Step | What happens | Expert’s time | Who does it | What to watch |
|---|---|---|---|---|
| 1. Extract | A recorded interview pulls out stories, opinions and the things your market gets wrong | About 1 hour a month | Expert and interviewer | Stories per interview you’d actually put your name to |
| 2. Bank | The conversation becomes a bank: stories, buyer language, contested beliefs | None | Interviewer or writer | Weeks of posts in the bank |
| 3. Publish | Three posts a week, written in your words, approved by you | 15 to 30 minutes a week to approve | Writer, expert approves | Whether buyers comment, not only peers |
| 4. Converse | Replies, comments on other people’s posts, DMs that turn into calls | Around 5 hours a week | Expert only | Inbound leads and discovery calls booked |
Why extract instead of asking the expert to write? Because ideas run out in about a week, and material from the actual work doesn’t. A regulatory consultant who answers “what did a client get wrong this month?” has more to say than one staring at a blank post. Good extraction questions are specific and a bit uncomfortable. What did FDA ask for last month that the client didn’t see coming? Which common piece of advice in your field do you think is wrong? What would you tell a founder before they hire anyone, including you? One hour of answers like that is a month of posts.
The bank matters as much as the interview. It holds three kinds of material. There are stories, meaning what happened this month and what it cost. There are the words buyers actually use, which are rarely the words consultants use. And there are the beliefs in the market that are quietly wrong, which make the posts people stop for.
Why three posts a week? Because FDA Blueprint tested it. David started at five posts a week and moved to three, Tuesday to Thursday, and engagement went up, as documented in the FDA Blueprint case study. More wasn’t better.
Why is step four the expert’s alone? Because conversation is where the pipeline actually turns, where a comment becomes a DM and a DM becomes a discovery call. David spends about 5 hours a week replying and following up, per the case study. There’s a reach reason too. AuthoredUp analysed more than 600,000 LinkedIn posts in 2025 and found posts with indirect comments, where commenters reply to each other, can see up to 2.4x the reach of regular posts. Somebody else can write the posts, but the replies have to come from you, because you’re the person the buyer is deciding about.
What happens in the first 90 days?
In the first 90 days the audience changes before the pipeline does. That’s the honest order. Reach and the right followers come first, and qualified conversations follow, which is why judging it at 30 days kills most programs before they work. The numbers below are from one client, FDA Blueprint, from verified LinkedIn analytics in the case study. One case is one case, so read them as what’s possible, not what’s typical.
What should you watch along the way? There’s no honest benchmark for a solo regulatory consultant, so don’t trust anyone who hands you one. Watch the direction of these three instead, against your own starting point.
| Checkpoint | What to watch | What it tells you |
|---|---|---|
| Day 30 | Who comments and who views your profile: buyers or peers | Whether you’re writing for the right room |
| Day 60 | DMs, inbound leads, and people who mention a post when they get in touch | Whether visibility is turning into conversations |
| Day 90 | Qualified discovery calls a month, against your baseline | Whether the pipeline itself has moved |
Here’s what that looked like for FDA Blueprint, from the same case study.
| Metric | Before | After 90 days |
|---|---|---|
| Impressions per 90 days | About 21,800 | 393,677 |
| Unique members reached | About 7,400 | 133,771 |
| Followers | About 3,900 | 5,100+ |
| Qualified intro calls a month | 3 to 4 | 12 to 16 |
| Deal flow from LinkedIn | 0 (all referral) | About 50% (David’s estimate) |
Before this, David had spent about 15k USD on ads that brought clicks from the wrong people, as he describes in the case study. His best post in the window, “FDA reviewers don’t know what your device does”, reached 49,253 impressions. There was no hook trick in it, just something only a former FDA reviewer could say with a straight face.
What kills a consultant’s pipeline? The 5 mistakes
These five mistakes kill more regulatory consultants’ pipelines than bad writing does. Most of them come from treating visibility as a side project.
1. Posting only when work is quiet
Posting only when work is quiet is the feast-and-famine loop from the first section. You post when you need clients and stop when you have them, so the pipeline is always a quarter behind your calendar.
2. Hiring a writer who works from a brief
A writer can match your grammar. What they can’t match is your judgment, and that only comes out when somebody asks you the right question and you talk for an hour. The usual verdict, “they couldn’t match my depth”, is true, but it’s the wrong diagnosis. The problem was the input, not the writer.
3. Writing for your peers instead of your buyers
I told one AI medical device software firm exactly this: their posts were very technical, and the only people commenting were technical people who understood the language, not the people who would buy. Peer approval feels like progress. But the founder with the budget scrolls straight past a post about predicate strategy footnotes. Don’t dumb it down. Keep the depth, and write the first two lines about the consequence the buyer cares about, a delayed clearance, a burned runway, a board asking why, before you get into the mechanism.
4. Only resharing other people’s posts
Reposting FDA announcements or a partner’s post feels like staying active. But nobody finds out what you think from a repost, and nobody hires a consultant for their taste in links. With average LinkedIn reach down 34% in 2025, according to AuthoredUp’s analysis, the feed doesn’t have room for posts that don’t say anything of yours.
5. Buying volume instead of becoming known
Ads and mass outreach look like a shortcut. For a specialist they mostly buy attention from the wrong people, which is what happened to David’s 15k USD of ads, per the case study. High-ticket regulatory work gets bought on trust, and trust doesn’t come from a sequence of 20 cold messages a day.
Frequently asked questions
How do independent FDA regulatory consultants get new clients?
Most independent FDA regulatory consultants get new clients through referrals from former colleagues, clients and people who have seen their expertise. The consultants who stop depending on referrals alone publish what they know consistently, usually on LinkedIn, so device companies find them during the months of research before a shortlist. That research happens early: 94% of buying groups rank vendors before first contact, per 6sense.
How can a 510(k) consultant get clients without relying on referrals?
A 510(k) consultant gets clients without relying on referrals by becoming visible to device companies before they need a submission, not when they do. In practice that means a narrow niche, a steady cadence of posts drawn from real client work, and replying to the people who engage. Outbound can supplement it, but for a solo consultant it rarely survives a busy submission month.
Who helps regulatory consultants build a client pipeline?
Regulatory consultants usually get pipeline help from one of three places: a freelance ghostwriter, a general B2B marketing agency, or a done-with-you program built around interviews. Ghostwriters and agencies tend to work from briefs, which is where technical depth gets lost. Contour runs an interview-based program for independent regulatory, medtech and technical advisors, and you can see how it works or start with the free Pipeline Kit.
How long does it take for LinkedIn to bring in qualified calls?
LinkedIn usually takes about 90 days to bring qualified calls to a regulatory consultant, because the audience has to change before the pipeline does. FDA Blueprint went from 3 or 4 qualified calls a month to 12 to 16 within 90 days, per the case study. That’s one client, not a promise, and judging it at 30 days is the most common reason programs get cancelled too early.
Do paid ads work for regulatory consultants?
Paid ads rarely work for independent regulatory consultants, because the buyer is a small, specific group and ads optimise for clicks, not fit. David Pudwill of FDA Blueprint spent about 15k USD on ads that brought the wrong people, per the case study. Ads can amplify a consultant people already trust. They don’t create that trust on their own.
How many hours a week does this take for a solo consultant?
A visibility pipeline takes a solo regulatory consultant about one hour a month for the interview and a few minutes a week to approve posts. The bigger commitment is around five hours a week of replying and following up. The replies are the part that can’t be handed off. David Pudwill spends about five hours a week on it, almost all of it conversation, per the case study.
Should a solo regulatory consultant do cold outreach?
A solo regulatory consultant can do cold outreach, but it works far better on top of visibility than instead of it. A cold message from someone whose posts the buyer has already seen reads as familiar, and one from a stranger reads as a pitch. Edelman and LinkedIn’s 2024 research found 9 in 10 decision-makers are more receptive to outreach from companies that consistently publish high-quality thought leadership.